I couldn't live without ... PointClickCare Secure Conversations
Profile: Mastering by example
Day in the Life: Sniffing out wandering residents
by Shelly Mesure
By Gary Tetz
By Eleanor Feldman Barbera
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.